Zacks lowered shares of Novo Nordisk A/S (ADR) (NYSE:NVO) from an outperform rating to a neutral rating in a report released on Monday. Novo Nordisk A/S (ADR) (NYSE:NVO) stock opened at $42.48 in last session, and closed at $43.02, while the day range of NVO stock is $42.45 – $43.02. The stock showed a positive weekly performance of 8.69%.
ICON plc- Ordinary Shares (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced that its Chief Executive, Ciaran Murray, has been elected 2014 Chairman of the Association of Clinical Research Organizations (ACRO). ICON plc – Ordinary Shares (NASDAQ:ICLR) stock opened at $45.85, in last session and closed at $45.06, by losing -1.16%. The 52 week range of ICLR is $26.70 – $45.93. Company’s market capitalization is $2.79billion.
Gilead Sciences, Inc. (NASDAQ:GILD) has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for a once-daily fixed-dose combination of the NS5A inhibitor ledipasvir (LDV) 90 mg and the nucleotide analog polymerase inhibitor sofosbuvir (SOF) 400 mg for the treatment of chronic hepatitis C genotype 1 infection in adults. Gilead Sciences, Inc. (NASDAQ:GILD) stock advanced 1.01% and finished the last session at $81.80. The EPS of the stock remained 1.83. Company’s market capitalization is $125.52billion.
GlaxoSmithKline PLC (ADR) (NYSE:GSK) Tuesday said Simon Bicknall, a divisional vice president, exercised options over 12,650 shares at an exercise price of GBP11.23 per share and sold the shares at GBP16 each Monday. GlaxoSmithKline plc (ADR) (NYSE:GSK) stock opened the session at $53.50, and closed the session at $54.17. The 52 week range of the GSK stock remained $43.68 – $55.07 and the day range was $53.50 – $54.24.